Avenue Therapeutics Announces $3.25 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules

Journey Medical Corporation Appoints Joseph Benesch as Interim Chief Financial Officer

Checkpoint Therapeutics to Participate in the B. Riley Securities’ 3rd Annual Oncology Conference